(S)-nicotine multiple interactions ISO RGD:1352947 6480464 alpha-cobratoxin inhibits the reaction [Nicotine results in increased expression of GOLGA4 mRNA], Tubocurarine inhibits the reaction [Nicotine results in increased expression of GOLGA4 mRNA] CTD PMID:16949557 (S)-nicotine increases expression ISO RGD:1352947 6480464 Nicotine results in increased expression of GOLGA4 mRNA CTD PMID:16949557 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of GOLGA4 mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:1352947 6480464 1-nitropyrene results in increased expression of GOLGA4 mRNA CTD PMID:19041380 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GOLGA4 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1591925 6480464 Ethinyl Estradiol results in decreased expression of GOLGA4 mRNA CTD PMID:29097150 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1352947 6480464 Dihydrotestosterone results in increased expression of GOLGA4 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GOLGA4 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GOLGA4 mRNA CTD PMID:21570461 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GOLGA4 mRNA CTD PMID:18648102 acrolein multiple interactions ISO RGD:1352947 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GOLGA4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GOLGA4 mRNA CTD PMID:32699268 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GOLGA4 mRNA CTD PMID:19770486 aflatoxin M1 decreases expression ISO RGD:1352947 6480464 Aflatoxin M1 results in decreased expression of GOLGA4 mRNA CTD PMID:30928695 alpha-pinene multiple interactions ISO RGD:1352947 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GOLGA4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GOLGA4 mRNA CTD PMID:32699268 arsane decreases expression ISO RGD:1352947 6480464 Arsenic results in decreased expression of GOLGA4 mRNA CTD PMID:16835338 arsane affects methylation ISO RGD:1352947 6480464 Arsenic affects the methylation of GOLGA4 gene CTD PMID:25304211 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of GOLGA4 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:1352947 6480464 Arsenic results in decreased expression of GOLGA4 mRNA CTD PMID:16835338 arsenic atom affects methylation ISO RGD:1352947 6480464 Arsenic affects the methylation of GOLGA4 gene CTD PMID:25304211 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of GOLGA4 mRNA CTD PMID:19654921 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of GOLGA4 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1352947 6480464 Benzoapyrene affects the methylation of GOLGA4 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1352947 6480464 7 more ... CTD PMID:19150397 , PMID:26238291 bisphenol A increases expression ISO RGD:1591925 6480464 bisphenol A results in increased expression of GOLGA4 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1591925 6480464 bisphenol A results in increased methylation of GOLGA4 gene CTD PMID:28505145 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of GOLGA4 mRNA CTD PMID:24982889 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carmustine increases expression ISO RGD:1352947 6480464 Carmustine results in increased expression of GOLGA4 mRNA CTD PMID:15980968 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of GOLGA4 mRNA CTD PMID:28472532 cisplatin decreases phosphorylation EXP 6480464 Cisplatin results in decreased phosphorylation of GOLGA4 protein CTD PMID:22006019 cisplatin decreases expression ISO RGD:1591925 6480464 Cisplatin results in decreased expression of GOLGA4 mRNA CTD PMID:22023808 clorgyline increases expression ISO RGD:1352947 6480464 Clorgyline results in increased expression of GOLGA4 mRNA CTD PMID:19691856 copper(II) sulfate decreases expression ISO RGD:1352947 6480464 Copper Sulfate results in decreased expression of GOLGA4 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1352947 6480464 Cyclosporine results in increased expression of GOLGA4 mRNA CTD PMID:20106945 , PMID:25562108 dorsomorphin multiple interactions ISO RGD:1352947 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GOLGA4 mRNA CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of GOLGA4 mRNA CTD PMID:19277126 formaldehyde increases expression ISO RGD:1352947 6480464 Formaldehyde results in increased expression of GOLGA4 mRNA CTD PMID:23649840 hexadecanoic acid decreases phosphorylation ISO RGD:1352947 6480464 Palmitic Acid results in decreased phosphorylation of GOLGA4 protein CTD PMID:28073184 hydrogen peroxide decreases expression ISO RGD:1352947 6480464 Hydrogen Peroxide results in decreased expression of GOLGA4 mRNA CTD PMID:18951874 lead(0) affects splicing ISO RGD:1352947 6480464 Lead affects the splicing of GOLGA4 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1352947 6480464 Lead affects the splicing of GOLGA4 mRNA CTD PMID:28903495 linsidomine increases oxidation ISO RGD:1591925 6480464 linsidomine results in increased oxidation of GOLGA4 protein CTD PMID:28086193 Mecamylamine increases expression ISO RGD:1352947 6480464 Mecamylamine results in increased expression of GOLGA4 mRNA CTD PMID:16949557 methapyrilene decreases expression ISO RGD:1591925 6480464 Methapyrilene results in decreased expression of GOLGA4 mRNA CTD PMID:30467583 methyl methanesulfonate increases expression ISO RGD:1352947 6480464 Methyl Methanesulfonate results in increased expression of GOLGA4 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1352947 6480464 methylmercuric chloride results in decreased expression of GOLGA4 mRNA CTD PMID:28001369 nicotine multiple interactions ISO RGD:1352947 6480464 alpha-cobratoxin inhibits the reaction [Nicotine results in increased expression of GOLGA4 mRNA], Tubocurarine inhibits the reaction [Nicotine results in increased expression of GOLGA4 mRNA] CTD PMID:16949557 nicotine increases expression ISO RGD:1352947 6480464 Nicotine results in increased expression of GOLGA4 mRNA CTD PMID:16949557 oxaliplatin multiple interactions ISO RGD:1591925 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GOLGA4 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1352947 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GOLGA4 mRNA more ... CTD PMID:32699268 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of GOLGA4 mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1352947 6480464 perfluorooctane sulfonic acid results in decreased expression of GOLGA4 mRNA CTD PMID:27153767 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of GOLGA4 mRNA CTD PMID:23091169 PhIP increases expression ISO RGD:1591925 6480464 2-amino-1-methyl-6-phenylimidazo4, 5-bpyridine results in increased expression of GOLGA4 mRNA CTD PMID:15215175 rotenone increases expression ISO RGD:1591925 6480464 Rotenone results in increased expression of GOLGA4 mRNA CTD PMID:19013527 SB 431542 multiple interactions ISO RGD:1352947 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GOLGA4 mRNA CTD PMID:27188386 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of GOLGA4 mRNA CTD PMID:21795629 sodium arsenite affects methylation ISO RGD:1352947 6480464 sodium arsenite affects the methylation of GOLGA4 gene CTD PMID:28589171 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GOLGA4 mRNA CTD PMID:21641980 sunitinib increases expression ISO RGD:1352947 6480464 Sunitinib results in increased expression of GOLGA4 mRNA CTD PMID:31533062 testosterone enanthate affects expression ISO RGD:1352947 6480464 testosterone enanthate affects the expression of GOLGA4 mRNA CTD PMID:17440010 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of GOLGA4 mRNA CTD PMID:31919559 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of GOLGA4 mRNA CTD PMID:23131501 toluene increases expression ISO RGD:1352947 6480464 Toluene results in increased expression of GOLGA4 mRNA CTD PMID:28245982 topotecan multiple interactions ISO RGD:1591925 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GOLGA4 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1352947 6480464 trichostatin A results in increased expression of GOLGA4 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1352947 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GOLGA4 mRNA CTD PMID:27188386 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of GOLGA4 mRNA CTD PMID:28973697 trovafloxacin multiple interactions EXP 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of GOLGA4 mRNA CTD PMID:18930950 tubocurarine decreases expression ISO RGD:1352947 6480464 Tubocurarine results in decreased expression of GOLGA4 mRNA CTD PMID:16949557 tubocurarine multiple interactions ISO RGD:1352947 6480464 Tubocurarine inhibits the reaction [Nicotine results in increased expression of GOLGA4 mRNA] CTD PMID:16949557 tunicamycin increases expression ISO RGD:1352947 6480464 Tunicamycin results in increased expression of GOLGA4 mRNA CTD PMID:22378314